Cargando…

Risk factors and survival prediction of pancreatic cancer with lung metastases: A population-based study

BACKGROUND: The risk and prognosis of pancreatic cancer with lung metastasis (PCLM) are not well-defined. Thus, this study aimed to identify the risk and prognostic factors for these patients, and establish predictive nomogram models. METHODS: Patients diagnosed with PCLM between 2010 and 2016 were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Zong-Xi, Tu, Jun-Hao, Zhou, Bin, Huang, Yang, Liu, Yu-Lin, Xue, Xiao-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533144/ https://www.ncbi.nlm.nih.gov/pubmed/36212473 http://dx.doi.org/10.3389/fonc.2022.952531

Ejemplares similares

A nomogram diagnostic prediction model of pancreatic metastases of small cell lung carcinoma based on clinical characteristics, radiological features and biomarkers
por: Xu, Jian-Xia, et al.
Publicado: (2023)

Computer Tomography Radiomics-Based Nomogram in the Survival Prediction for Brain Metastases From Non-Small Cell Lung Cancer Underwent Whole Brain Radiotherapy
por: Zhang, Ji, et al.
Publicado: (2021)

Predicting Survival Duration With MRI Radiomics of Brain Metastases From Non-small Cell Lung Cancer
por: Chen, Bihong T., et al.
Publicado: (2021)

Patterns of Extrathoracic Metastases in Different Histological Types of Lung Cancer
por: Wang, Xuan, et al.
Publicado: (2020)

Analysis of Prognostic Factors Affecting the Brain Metastases Free Survival and Survival After Brain Metastases in Breast Cancer
por: Xiao, Weikai, et al.
Publicado: (2020)

Radiomic Signatures for Predicting EGFR Mutation Status in Lung Cancer Brain Metastases
por: Zheng, Lie, et al.
Publicado: (2022)

Risk Factors and Survival of Patients With Liver Metastases at Initial Metastatic Breast Cancer Diagnosis in Han Population
por: Lin, Shaoyan, et al.
Publicado: (2021)

Survival Outcomes of Local Compared With Systemic First Treatment of Non-Small Cell Lung Cancer Brain Metastases
por: Liu, Hong-Mei, et al.
Publicado: (2021)

Treatment Patterns and Survival Outcomes of Non-Small Cell Lung Cancer Patients Initially Diagnosed With Brain Metastases in Real-World Clinical Practice
por: Chen, Xin-Ru, et al.
Publicado: (2020)

Prediction of distant organ metastasis and overall survival of lung cancer patients: a SEER population−based cohort study
por: Hao, Yongping, et al.
Publicado: (2023)

Radiomics Analysis of Multiparametric MRI for Prediction of Synchronous Lung Metastases in Osteosarcoma
por: Luo, Zhendong, et al.
Publicado: (2022)

Survival prognostic factors for differentiated thyroid cancer patients with pulmonary metastases: A systematic review and meta-analysis
por: Zhao, Hao, et al.
Publicado: (2022)

Lung Metastases in Newly Diagnosed Esophageal Cancer: A Population-Based Study
por: Guo, Jida, et al.
Publicado: (2021)

Individualized Nomogram for Predicting Survival in Patients with Brain Metastases After Stereotactic Radiosurgery Utilizing Driver Gene Mutations and Volumetric Surrogates
por: Zhou, Cheng, et al.
Publicado: (2021)

The Role of Primary Tumor Resection in Patients With Pancreatic Neuroendocrine Tumors With Liver Metastases
por: Mou, Yu, et al.
Publicado: (2022)

A rare case of pancreatic adenocarcinoma metastasized to the bladder
por: Pike, James Frederick W., et al.
Publicado: (2020)

Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?
por: Nieder, Carsten, et al.
Publicado: (2023)

Folate receptor-positive circulating tumor cells predict survival and recurrence patterns in patients undergoing resection for pancreatic cancer
por: Cheng, Hao, et al.
Publicado: (2022)

Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy
por: Ye, Shuai, et al.
Publicado: (2022)

A Novel Secreted Protein-Related Gene Signature Predicts Overall Survival and Is Associated With Tumor Immunity in Patients With Lung Adenocarcinoma
por: Chen, Shuaijun, et al.
Publicado: (2022)

Reirradiation of Whole Brain for Recurrent Brain Metastases: A Case Report of Lung Cancer With 12-Year Survival
por: Li, Minmin, et al.
Publicado: (2021)

Genomic Features of Organ-Specific Metastases in Lung Adenocarcinoma
por: Feng, Alei, et al.
Publicado: (2022)

Deep Inguinal Lymph Node Metastases Can Predict Pelvic Lymph Node Metastases and Prognosis in Penile Squamous Cell Carcinoma
por: Yang, Zhenyu, et al.
Publicado: (2021)

A Risk Signature With Inflammatory and T Immune Cells Infiltration in Colorectal Cancer Predicting Distant Metastases and Efficiency of Chemotherapy
por: Hu, Xiang, et al.
Publicado: (2019)

A Nomogram for Predicting Multiple Metastases in Metastatic Colorectal Cancer Patients: A Large Population-Based Study
por: Ge, Yuhang, et al.
Publicado: (2021)

Development and Validation of a Nomogram to Predict Survival in Pancreatic Head Ductal Adenocarcinoma After Pancreaticoduodenectomy
por: Peng, Feng, et al.
Publicado: (2021)

Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy
por: Ye, Shuai, et al.
Publicado: (2023)

Development and Validation of Nomograms to Predict Overall Survival and Cancer-Specific Survival in Patients With Pancreatic Adenosquamous Carcinoma
por: Yang, Zhen, et al.
Publicado: (2022)

Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients With Advanced Lung Adenocarcinoma
por: Guo, Long-Hua, et al.
Publicado: (2020)

Clinical determinants impacting overall survival of patients with operable brain metastases from non-small cell lung cancer
por: Piffko, Andras, et al.
Publicado: (2022)

Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer
por: Althoff, Friederike C., et al.
Publicado: (2023)

Brain metastases: It takes two factors for a primary cancer to metastasize to brain
por: Liu, Dingyun, et al.
Publicado: (2022)

Predictive value of baseline metabolic tumor burden on (18)F-FDG PET/CT for brain metastases in patients with locally advanced non-small-cell lung cancer
por: Shang, Jingjie, et al.
Publicado: (2022)

Case Report: Dacomitinib is effective in lung adenocarcinoma with rare EGFR mutation L747P and brain metastases
por: Li, Yibin, et al.
Publicado: (2022)

Editorial: Brain and leptomeningeal metastases in lung cancer
por: Vavalà, Tiziana, et al.
Publicado: (2023)

Case Report: Pulmonary Metastases From Epithelioid Sarcoma in Extremity Favourably Responding to Immunotherapy With Camrelizumab
por: Gong, Tao-Jun, et al.
Publicado: (2021)

Postoperative survival of extrahepatic and intrahepatic cholangiocarcinoma after surgery: a population-based cohort
por: Liu, Wei-Wen, et al.
Publicado: (2022)

Value of (18)F-FDG PET/CT-Based Radiomics Nomogram to Predict Survival Outcomes and Guide Personalized Targeted Therapy in Lung Adenocarcinoma With EGFR Mutations
por: Yang, Bin, et al.
Publicado: (2020)

Novel Nanoparticle-Based Cancer Treatment, Effectively Inhibits Lung Metastases and Improves Survival in a Murine Breast Cancer Model
por: Kraus, Sarah, et al.
Publicado: (2021)

Applying machine learning techniques to predict the risk of lung metastases from rectal cancer: a real-world retrospective study
por: Qiu, Binxu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ilemr3n0mhufl9hd9nodgs21bc